Adverse Drug Reactions, Intoxications and Interactions of Neuropsychotropic Medications
- 5 November 2022
- book chapter
- Published by Springer Nature
- p. 361-414
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobioticsCritical Care, 2012
- Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of SchizophreniaNeuropsychopharmacology, 2011
- Differential actions of ethanol and trichloroethanol at sites in the M3 and M4 domains of the NMDA receptor GluN2A (NR2A) subunitBritish Journal of Pharmacology, 2009
- [3H]Chlorpromazine Photolabeling of the Torpedo Nicotinic Acetylcholine Receptor Identifies Two State-Dependent Binding Sites in the Ion ChannelBiochemistry, 2009
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- Value and Actuality of the Prescription Information for Therapeutic Drug Monitoring of Psychopharmaceuticals: A Comparison with the Medico-Scientific EvidencePharmacopsychiatry, 2007
- Adverse Events, Including Death, Associated with the Use of 1,4-ButanediolNew England Journal of Medicine, 2001
- The d- and l- isomers of methadone bind to the non-competitive site on the N-methyl-d-aspartate (NMDA) receptor in rat forebrain and spinal cordNeuroscience Letters, 1997
- Adverse Effects of ??1-Adrenergic Blocking DrugsDrug Safety, 1994
- Harmonisation in PharmacovigilanceDrug Safety, 1994